Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Jilg

Showing results (91-100 of 144) with videos related to

Pageof 15
Sort By:
The Journal of Infection|July 1, 1983
Immune responses to active and passive-active vaccination against hepatitis BF Deinhardt, R Zachoval, W Jilg, et al.
Journal of Medical Virology|August 10, 1999
Prevalence of precore mutants in anti-HBe-positive hepatitis B virus carriers in GermanyA Knöll, A Rohrhofer, B Kochanowski, et al.
Journal of Virology|October 10, 1998
Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytesS Pepperl, G Benninger-Döring, S Modrow, et al.
Virology|August 1, 1994
The Epstein-Barr virus-encoded glycoprotein gp 110 (BALF 4) can serve as a target for antibody-dependent cell-mediated cytotoxicity (ADCC)W Jilg, C Bogedain, H Mairhofer, et al.
Journal of Medical Virology|May 21, 1999
A novel deletion mutant of hepatitis B virus surface antigenK M Weinberger, G Zoulek, T Bauer, et al.
Vaccine|July 14, 1999
Diphtheria booster vaccination: one or two injections?U Nicolay, O E Girgsdies, A Banzhoff, et al.
Vaccine|March 1, 1997
Long-term persistence of anti-HAV antibodies following active immunization with hepatitis A vaccineH Maiwald, W Jilg, H L Bock, et al.
Journal of Virology|February 1, 1994
Different activation of Epstein-Barr virus immediate-early and early genes in Burkitt lymphoma cells and lymphoblastoid cell linesC Bogedain, P Alliger, F Schwarzmann, et al.
MMW Fortschritte Der Medizin|January 4, 2001
[Combined vaccine against polio, diphtheria and tetanus. Closing vaccination gaps!]A Banzhoff, N Donner-Banzhoff, C Schwenke, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|June 1, 1997
[High percentage of isolated anti-HBc-positive persons among prisoners]S Neifer, B Molz, U Sucker, et al.
Pageof 15

Showing results (91-100 of 144) with videos related to

Sort By:
Pageof 15
The Journal of Infection|July 1, 1983
Immune responses to active and passive-active vaccination against hepatitis BF Deinhardt, R Zachoval, W Jilg, et al.
Journal of Medical Virology|August 10, 1999
Prevalence of precore mutants in anti-HBe-positive hepatitis B virus carriers in GermanyA Knöll, A Rohrhofer, B Kochanowski, et al.
Journal of Virology|October 10, 1998
Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytesS Pepperl, G Benninger-Döring, S Modrow, et al.
Virology|August 1, 1994
The Epstein-Barr virus-encoded glycoprotein gp 110 (BALF 4) can serve as a target for antibody-dependent cell-mediated cytotoxicity (ADCC)W Jilg, C Bogedain, H Mairhofer, et al.
Journal of Medical Virology|May 21, 1999
A novel deletion mutant of hepatitis B virus surface antigenK M Weinberger, G Zoulek, T Bauer, et al.
Vaccine|July 14, 1999
Diphtheria booster vaccination: one or two injections?U Nicolay, O E Girgsdies, A Banzhoff, et al.
Vaccine|March 1, 1997
Long-term persistence of anti-HAV antibodies following active immunization with hepatitis A vaccineH Maiwald, W Jilg, H L Bock, et al.
Journal of Virology|February 1, 1994
Different activation of Epstein-Barr virus immediate-early and early genes in Burkitt lymphoma cells and lymphoblastoid cell linesC Bogedain, P Alliger, F Schwarzmann, et al.
MMW Fortschritte Der Medizin|January 4, 2001
[Combined vaccine against polio, diphtheria and tetanus. Closing vaccination gaps!]A Banzhoff, N Donner-Banzhoff, C Schwenke, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|June 1, 1997
[High percentage of isolated anti-HBc-positive persons among prisoners]S Neifer, B Molz, U Sucker, et al.
Pageof 15